Possible drug-associated pancreatitis after paclitaxel- cremophor administration

Pharmacotherapy

Volumn 20, Issue 1 I, 2000, Pages 95-97

  Mills, Kimberly M ^a   Johnson, Deborah M ^b   Middlebrooks, Mark ^b   Burton, Gary V ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; CIMETIDINE; CREMOPHOR; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIMETHYL SULFOXIDE; DIPHENHYDRAMINE; DOXORUBICIN; FLUOROURACIL; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; ONDANSETRON; PACLITAXEL; SEROTONIN 3 ANTAGONIST; STEROID;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYDROPHOBICITY; INTRAVENOUS ADMINISTRATION; PANCREATITIS; PARTIAL MASTECTOMY; SUCTION DRAINAGE;

EID: 0033986405     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.1.95.34653     Document Type: Article

References (19)

1. Hudis C, Riccio L, Holmes F, et al. Phase II study of semisynthetic paclitaxel in metastatic breast cancer. Eur J Cancer 1997;33(13):2198-2202.
2. Hoff PM, Valero V, Holmes FA, Whealen H, Hudis C, Hortobagyi G. Paclitaxel-induced pancreatitis: a case report. J Natl Cancer Inst 1997;89(1):91-3.
3. Runzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas 1996;13(1):100-9.
4. Kaplan MH, Dreiling DA. Steroids revisited. II. Was cortisone responsible for the pancreatitis? Am J Gastroenterol 1997;67(2):141-7.
5. Alberti-Flor JJ. Pancreatitis associated with ondansetron. J Natl Cancer Inst 1995;87(9):689-90.
6. Ueda T, Takeyama Y, Kaneda K, Adachi M, Ohyanagi H, Saitoh Y. Protective effect of a microtubule stabilizer Taxol on cerulein-induced acute pancreatitis in rat. J Clin Invest 1992;89:234-43.
7. Ueda T, Takeyama Y, Adachi M, et al. Effect of the microtubule-disrupting drug colchicine on rat cerulein-induced pancreatitis in comparison with the microtubule stabilizer Taxol. Pancreas 1995;11(3):294-302.
8. McEvoy GK, Litvak K, Welsh O, eds. Antineoplastic agents. In: AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists, 1996:762-6.
9. Paradis R, Page M. New active paclitaxel amino acids derivatives with improved water solubility. Anticancer Res 1998;18:2711-16.
10. Brouwer B, Verweij J, Hauns B, et al. Linearized colorimetric assay for Cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusions. Anal Biochem 1998;261: 198-202.
11. Terwogt JM, Nuijen B, Ten Bokkel Huinink WW, Beijnen JH. Alternative formulations of paclitaxel. Cancer Treat Rev 1997;23:87-95
12. Sparreboom A, Loos WJ, Verweij J, et al. Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay. Anal Biochem 1998;255:171-5.
13. Weiss RB, Donehower RC, Wiernik PH, et al. Hypersensitivity reactions from Taxol. J Clin Oncol 1990;8(7):1263-8.
14. Goldspiel BR. Guidelines for administration. In: McGuire WP, Rowinsky EK, eds. Paclitaxel in cancer treatment. New York: Dekker, 1995:175-86.
15. Mead Johnson Oncology Products. Taxol (paclitaxel) injection package insert. Princeton, NJ;April 1998.
16. Sonnichsen DS, Liu Q, Schuetz EG, Schuetz JD, Pappo A, MV Relling. Variability in human cytochrome p450 paclitaxel metabolism. J Pharmacol Exp Ther 1995;275:566-75.
17. Ko CW, Gooley T, Schoch HG, et al. Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis. Bone Marrow Transplant 1997;20(12):1081-6.
18. Echigo Y, Inoue K, Kogire M, et al. Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. Arch Surg 1995;130(1):64-8.
19. Foitzik T, Forgacs B, Ryschich E, et al. Effect of different immunosuppressive agents on acute pancreatitis. Transplantation 1998;65(8):1030-6.